Your browser doesn't support javascript.
loading
Efficacy of vaccination against equine herpesvirus type 1 (EHV-1) infection: Systematic review and meta-analysis of randomised controlled challenge trials.
Marenzoni, Maria Luisa; De Waure, Chiara; Timoney, Peter J.
Afiliação
  • Marenzoni ML; Department of Veterinary Medicine, University of Perugia, Perugia, Italy.
  • De Waure C; Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Timoney PJ; Department of Veterinary Science, Maxwell H. Gluck Equine Research Center, Lexington, Kentucky, USA.
Equine Vet J ; 55(3): 389-404, 2023 May.
Article em En | MEDLINE | ID: mdl-35946376
ABSTRACT

BACKGROUND:

Equid herpesvirus type 1 (EHV-1) infection can cause a range of disease syndromes of variable severity that can result in a lethal outcome and restriction of horse movements, especially in the case of outbreaks involving neurological disease. Vaccination is one of the tools used to control the infection. It is widely known that vaccination is not completely effective in ensuring protection against disease caused by this virus. In fact, the real efficacy of vaccination against EHV-1 related disease has not been measured and no systematic reviews exist on this topic.

OBJECTIVES:

To perform a systematic review and meta-analysis on the efficacy of commercial or candidate vaccines against EHV-1 in randomised controlled trials (RCT) all of which involved experimental challenge of the test subjects. STUDY

DESIGN:

Systematic review and meta-analysis.

METHODS:

RCTs were searched using the search algorithm (([equid herpesvirus* OR equine herpesvirus* OR EHV-1]) AND vaccin*) AND (trial OR experimental OR challenge) on PubMed, Science Citation Index Expanded, Scopus, and CAB Abstracts. Where appropriate, meta-analysis was performed using RevMan 5.4.

RESULTS:

Eight studies were selected and were analysed for their respective characteristics and possible shortcomings. The results of RCTs revealed that there was a general improvement in the clinical and virological outcomes of EHV-1 infection following vaccination, but that the effects were very slight. The reduced beneficial effect is probably amplified by the paucity of detailed data reported in the studies that did not allow for the comparison of parameters in many of the cases analysed. MAIN

LIMITATIONS:

The remarkable heterogeneity and the poor quality of reporting of the selected studies.

CONCLUSIONS:

Meta-analysis has shown that EHV-1 vaccination generally results in a slight improvement in clinical and virological outcomes, although not to a significant extent. The cumulative results have probably been affected by the lack of information on some parameters not systematically reported in the studies. An improvement in the standard of reporting and better standardisation of the data collected would likely have improved the quality of each study and enabled more effective comparison of the studies with each other.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Herpesvirus Equídeo 1 / Infecções por Herpesviridae / Vacinas contra Herpesvirus / Doenças dos Cavalos Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Animals Idioma: En Revista: Equine Vet J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Herpesvirus Equídeo 1 / Infecções por Herpesviridae / Vacinas contra Herpesvirus / Doenças dos Cavalos Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Animals Idioma: En Revista: Equine Vet J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália